Economic Program | Letter

Letter Supporting the Creation of a Regulatory Pathway for “Biosimilar” Medicines

by Rob Keast

Print View_download_pdf Share
Font Size: aaa

SUMMARY

Letter in support of the creation of a regulatory pathway for “biosimilar” medicines.

Third Way encourages the creation of a regulatory pathway for “biosimilar” medicines. Third Way has been an ardent supporter of the creation of a regulatory pathway as a way to offer patients access to lower-cost medications.

Back_to_top